Annual FCF
$4.57 B
-$939.74 M-17.07%
December 1, 2024
Summary
- As of February 7, 2025, GSK annual free cash flow is $4.57 billion, with the most recent change of -$939.74 million (-17.07%) on December 1, 2024.
- During the last 3 years, GSK annual FCF has fallen by -$2.72 billion (-37.37%).
- GSK annual FCF is now -51.94% below its all-time high of $9.50 billion, reached on December 31, 2008.
Performance
GSK Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
$1.75 B
+$905.41 M+107.28%
September 30, 2024
Summary
- As of February 7, 2025, GSK quarterly free cash flow is $1.75 billion, with the most recent change of +$905.41 million (+107.28%) on September 30, 2024.
- Over the past year, GSK quarterly FCF has dropped by -$426.60 million (-19.61%).
- GSK quarterly FCF is now -63.15% below its all-time high of $4.75 billion, reached on December 31, 2018.
Performance
GSK Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
$6.05 B
-$426.60 M-6.58%
September 30, 2024
Summary
- As of February 7, 2025, GSK TTM free cash flow is $6.05 billion, with the most recent change of -$426.60 million (-6.58%) on September 30, 2024.
- Over the past year, GSK TTM FCF has increased by +$1.83 billion (+43.41%).
- GSK TTM FCF is now -42.62% below its all-time high of $10.55 billion, reached on June 30, 2010.
Performance
GSK TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
GSK Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.1% | -19.6% | +43.4% |
| 3 y3 years | -37.4% | -33.9% | -39.3% |
| 5 y5 years | -39.0% | -33.9% | -39.3% |
GSK Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -37.4% | at low | -60.5% | +402.4% | -40.9% | +117.6% |
| 5 y | 5-year | -45.2% | at low | -60.5% | +402.4% | -40.9% | +117.6% |
| alltime | all time | -51.9% | +3342.8% | -63.1% | +135.8% | -42.6% | +680.5% |
GSK Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $4.57 B(-17.1%) | - | - |
| Sep 2024 | - | $1.75 B(+107.3%) | $6.05 B(-6.6%) |
| Jun 2024 | - | $843.95 M(+68.4%) | $6.48 B(-1.6%) |
| Mar 2024 | - | $501.01 M(-83.1%) | $6.58 B(+19.6%) |
| Dec 2023 | $5.50 B(-13.6%) | $2.96 B(+36.0%) | $5.50 B(+30.4%) |
| Sep 2023 | - | $2.18 B(+129.3%) | $4.22 B(+51.7%) |
| Jun 2023 | - | $949.07 M(-264.0%) | $2.78 B(-11.6%) |
| Mar 2023 | - | -$578.58 M(-134.6%) | $3.15 B(-50.6%) |
| Dec 2022 | $6.37 B(-12.6%) | $1.67 B(+127.1%) | $6.37 B(-30.1%) |
| Sep 2022 | - | $737.05 M(-43.9%) | $9.12 B(-11.0%) |
| Jun 2022 | - | $1.31 B(-50.3%) | $10.25 B(+2.8%) |
| Mar 2022 | - | $2.65 B(-40.2%) | $9.97 B(+36.7%) |
| Dec 2021 | $7.29 B(-12.6%) | $4.42 B(+137.1%) | $7.29 B(+3.0%) |
| Sep 2021 | - | $1.87 B(+80.9%) | $7.08 B(+25.4%) |
| Jun 2021 | - | $1.03 B(-3352.1%) | $5.64 B(-24.9%) |
| Mar 2021 | - | -$31.71 M(-100.8%) | $7.51 B(-9.9%) |
| Dec 2020 | $8.34 B(+11.5%) | $4.21 B(+878.3%) | $8.34 B(+8.3%) |
| Sep 2020 | - | $430.57 M(-85.1%) | $7.70 B(-21.0%) |
| Jun 2020 | - | $2.90 B(+264.1%) | $9.74 B(+24.8%) |
| Mar 2020 | - | $795.95 M(-77.7%) | $7.81 B(+4.4%) |
| Dec 2019 | $7.48 B(-15.4%) | $3.57 B(+44.4%) | $7.48 B(-13.6%) |
| Sep 2019 | - | $2.47 B(+157.0%) | $8.65 B(+5.1%) |
| Jun 2019 | - | $962.73 M(+105.8%) | $8.23 B(-4.3%) |
| Mar 2019 | - | $467.69 M(-90.1%) | $8.60 B(-2.7%) |
| Dec 2018 | $8.84 B(+45.2%) | $4.75 B(+131.1%) | $8.84 B(+28.6%) |
| Sep 2018 | - | $2.05 B(+54.4%) | $6.88 B(+2.8%) |
| Jun 2018 | - | $1.33 B(+88.4%) | $6.69 B(+13.5%) |
| Mar 2018 | - | $706.38 M(-74.6%) | $5.89 B(-3.2%) |
| Dec 2017 | $6.09 B(+8.4%) | $2.78 B(+49.0%) | $6.09 B(-4.9%) |
| Sep 2017 | - | $1.87 B(+249.1%) | $6.41 B(+4.5%) |
| Jun 2017 | - | $535.18 M(-40.6%) | $6.13 B(-8.3%) |
| Mar 2017 | - | $901.66 M(-70.9%) | $6.68 B(+19.0%) |
| Dec 2016 | $5.62 B(+450.1%) | $3.10 B(+94.8%) | $5.62 B(+48.7%) |
| Sep 2016 | - | $1.59 B(+46.1%) | $3.78 B(+68.6%) |
| Jun 2016 | - | $1.09 B(-756.2%) | $2.24 B(+164.4%) |
| Mar 2016 | - | -$166.06 M(-113.2%) | $847.22 M(-17.0%) |
| Dec 2015 | $1.02 B(-81.9%) | $1.26 B(+2174.4%) | $1.02 B(-57.4%) |
| Sep 2015 | - | $55.45 M(-118.3%) | $2.40 B(-36.1%) |
| Jun 2015 | - | -$303.21 M(-4100.7%) | $3.75 B(-20.1%) |
| Mar 2015 | - | $7.58 M(-99.7%) | $4.70 B(-16.8%) |
| Dec 2014 | $5.65 B(-34.6%) | $2.64 B(+87.4%) | $5.65 B(-0.9%) |
| Sep 2014 | - | $1.41 B(+119.2%) | $5.70 B(-16.6%) |
| Jun 2014 | - | $642.38 M(-32.8%) | $6.83 B(-16.2%) |
| Mar 2014 | - | $956.35 M(-64.5%) | $8.15 B(-5.7%) |
| Dec 2013 | $8.64 B(+90.9%) | $2.69 B(+6.0%) | $8.64 B(+5.9%) |
| Sep 2013 | - | $2.54 B(+29.7%) | $8.16 B(+79.4%) |
| Jun 2013 | - | $1.96 B(+35.6%) | $4.55 B(-4.8%) |
| Mar 2013 | - | $1.44 B(-34.7%) | $4.78 B(+5.6%) |
| Dec 2012 | $4.52 B(-42.7%) | $2.21 B(-307.1%) | $4.52 B(-9.3%) |
| Sep 2012 | - | -$1.07 B(-148.8%) | $4.99 B(-41.3%) |
| Jun 2012 | - | $2.19 B(+84.2%) | $8.50 B(+7.2%) |
| Mar 2012 | - | $1.19 B(-55.5%) | $7.93 B(+0.5%) |
| Dec 2011 | $7.89 B | $2.67 B(+9.4%) | $7.89 B(+16.8%) |
| Sep 2011 | - | $2.45 B(+50.6%) | $6.76 B(+24.8%) |
| Jun 2011 | - | $1.62 B(+41.1%) | $5.42 B(-14.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | $1.15 B(-25.3%) | $6.31 B(-20.7%) |
| Dec 2010 | $7.96 B(-14.9%) | $1.54 B(+39.7%) | $7.96 B(-7.8%) |
| Sep 2010 | - | $1.10 B(-56.2%) | $8.63 B(-18.1%) |
| Jun 2010 | - | $2.52 B(-10.2%) | $10.55 B(+3.3%) |
| Mar 2010 | - | $2.80 B(+26.4%) | $10.21 B(+9.2%) |
| Dec 2009 | $9.35 B(-1.6%) | $2.22 B(-26.5%) | $9.35 B(-1.4%) |
| Sep 2009 | - | $3.02 B(+38.5%) | $9.48 B(+6.6%) |
| Jun 2009 | - | $2.18 B(+12.4%) | $8.90 B(+4.7%) |
| Mar 2009 | - | $1.94 B(-17.4%) | $8.50 B(-10.5%) |
| Dec 2008 | $9.50 B(+18.0%) | $2.35 B(-3.6%) | $9.50 B(+9.9%) |
| Sep 2008 | - | $2.43 B(+36.7%) | $8.64 B(-8.8%) |
| Jun 2008 | - | $1.78 B(-39.4%) | $9.47 B(+1.0%) |
| Mar 2008 | - | $2.94 B(+96.9%) | $9.38 B(+16.5%) |
| Dec 2007 | $8.05 B(+57.8%) | $1.49 B(-54.3%) | $8.05 B(-7.7%) |
| Sep 2007 | - | $3.26 B(+93.6%) | $8.72 B(+107.9%) |
| Jun 2007 | - | $1.69 B(+4.9%) | $4.19 B(+5.1%) |
| Mar 2007 | - | $1.61 B(-25.7%) | $3.99 B(-21.7%) |
| Dec 2006 | $5.10 B(-41.3%) | $2.16 B(-271.6%) | $5.10 B(-2.1%) |
| Sep 2006 | - | -$1.26 B(-185.0%) | $5.21 B(-39.0%) |
| Jun 2006 | - | $1.48 B(-45.4%) | $8.54 B(-10.1%) |
| Mar 2006 | - | $2.72 B(+19.5%) | $9.49 B(+9.3%) |
| Dec 2005 | $8.69 B(+21.6%) | $2.27 B(+10.0%) | $8.69 B(+20.8%) |
| Sep 2005 | - | $2.07 B(-15.2%) | $7.19 B(+9.6%) |
| Jun 2005 | - | $2.44 B(+27.5%) | $6.56 B(-4.6%) |
| Mar 2005 | - | $1.91 B(+146.4%) | $6.88 B(-3.8%) |
| Dec 2004 | $7.15 B(+9.7%) | $775.96 M(-45.9%) | $7.15 B(+50.2%) |
| Sep 2004 | - | $1.43 B(-47.9%) | $4.76 B(-28.5%) |
| Jun 2004 | - | $2.75 B(+26.2%) | $6.65 B(-7.9%) |
| Mar 2004 | - | $2.18 B(-235.4%) | $7.22 B(+10.9%) |
| Dec 2003 | $6.52 B(+136.4%) | -$1.61 B(-148.4%) | $6.52 B(+100.9%) |
| Sep 2003 | - | $3.33 B(+0.1%) | $3.24 B(+4.9%) |
| Jun 2003 | - | $3.32 B(+125.7%) | $3.09 B(+25.7%) |
| Mar 2003 | - | $1.47 B(-130.2%) | $2.46 B(-10.8%) |
| Dec 2002 | $2.76 B(-45.2%) | -$4.88 B(-253.7%) | $2.76 B(-60.9%) |
| Sep 2002 | - | $3.18 B(+18.1%) | $7.04 B(+18.6%) |
| Jun 2002 | - | $2.69 B(+52.1%) | $5.94 B(+5.3%) |
| Mar 2002 | - | $1.77 B(-395.8%) | $5.64 B(+12.1%) |
| Dec 2001 | $5.03 B(+343.0%) | -$598.36 M(-128.9%) | $5.03 B(+310.2%) |
| Sep 2001 | - | $2.07 B(-13.5%) | $1.23 B(-56.7%) |
| Jun 2001 | - | $2.39 B(+106.3%) | $2.83 B(+264.9%) |
| Mar 2001 | - | $1.16 B(-126.4%) | $775.54 M(-31.7%) |
| Dec 2000 | $1.14 B(-906.4%) | -$4.40 B(-219.7%) | $1.14 B(-79.5%) |
| Sep 2000 | - | $3.68 B(+979.9%) | $5.54 B(+197.5%) |
| Jun 2000 | - | $340.38 M(-77.6%) | $1.86 B(+22.4%) |
| Mar 2000 | - | $1.52 B | $1.52 B |
| Dec 1999 | -$140.78 M(+30.7%) | - | - |
| Dec 1998 | -$107.73 M(-132.9%) | - | - |
| Dec 1997 | $327.65 M(-53.2%) | - | - |
| Dec 1996 | $699.73 M(-22.0%) | - | - |
| Dec 1995 | $896.54 M(-71.1%) | - | - |
| Jun 1995 | $3.10 B(+333.1%) | - | - |
| Jun 1994 | $715.41 M(+38.0%) | - | - |
| Jun 1993 | $518.52 M(+367.9%) | - | - |
| Jun 1992 | $110.82 M(+563.6%) | - | - |
| Jun 1991 | $16.70 M | - | - |
FAQ
- What is GSK annual free cash flow?
- What is the all time high annual FCF for GSK?
- What is GSK annual FCF year-on-year change?
- What is GSK quarterly free cash flow?
- What is the all time high quarterly FCF for GSK?
- What is GSK quarterly FCF year-on-year change?
- What is GSK TTM free cash flow?
- What is the all time high TTM FCF for GSK?
- What is GSK TTM FCF year-on-year change?
What is GSK annual free cash flow?
The current annual FCF of GSK is $4.57 B
What is the all time high annual FCF for GSK?
GSK all-time high annual free cash flow is $9.50 B
What is GSK annual FCF year-on-year change?
Over the past year, GSK annual free cash flow has changed by -$939.74 M (-17.07%)
What is GSK quarterly free cash flow?
The current quarterly FCF of GSK is $1.75 B
What is the all time high quarterly FCF for GSK?
GSK all-time high quarterly free cash flow is $4.75 B
What is GSK quarterly FCF year-on-year change?
Over the past year, GSK quarterly free cash flow has changed by -$426.60 M (-19.61%)
What is GSK TTM free cash flow?
The current TTM FCF of GSK is $6.05 B
What is the all time high TTM FCF for GSK?
GSK all-time high TTM free cash flow is $10.55 B
What is GSK TTM FCF year-on-year change?
Over the past year, GSK TTM free cash flow has changed by +$1.83 B (+43.41%)